CDNA vs PH · rev $333.8M vs P/E 28, rev $19.85B
CareDx Inc (CDNA) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CDNA currently screens at market cap $1.18B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CDNA and PH stock pages for the full models.
Not investment advice.